Kent Lake Capital LLC Has $15.74 Million Position in Veradigm Inc. (NASDAQ:MDRX)

Kent Lake Capital LLC raised its stake in Veradigm Inc. (NASDAQ:MDRX - Free Report) by 62.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,500,000 shares of the software maker's stock after acquiring an additional 575,000 shares during the period. Veradigm comprises about 6.1% of Kent Lake Capital LLC's investment portfolio, making the stock its 2nd largest position. Kent Lake Capital LLC owned 1.37% of Veradigm worth $15,735,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently bought and sold shares of the stock. Advisor Group Holdings Inc. boosted its stake in Veradigm by 15.6% in the fourth quarter. Advisor Group Holdings Inc. now owns 4,833 shares of the software maker's stock worth $85,000 after purchasing an additional 651 shares in the last quarter. PNC Financial Services Group Inc. boosted its stake in Veradigm by 2.7% in the third quarter. PNC Financial Services Group Inc. now owns 32,052 shares of the software maker's stock worth $421,000 after purchasing an additional 836 shares in the last quarter. Prelude Capital Management LLC boosted its stake in Veradigm by 8.9% in the third quarter. Prelude Capital Management LLC now owns 11,428 shares of the software maker's stock worth $174,000 after purchasing an additional 930 shares in the last quarter. Covestor Ltd boosted its stake in Veradigm by 10.3% in the third quarter. Covestor Ltd now owns 10,336 shares of the software maker's stock worth $136,000 after purchasing an additional 966 shares in the last quarter. Finally, Bank of Montreal Can boosted its stake in Veradigm by 3.6% in the first quarter. Bank of Montreal Can now owns 34,210 shares of the software maker's stock worth $768,000 after purchasing an additional 1,198 shares in the last quarter.

Veradigm Stock Up 1.9 %

Shares of NASDAQ:MDRX traded up $0.15 during mid-day trading on Friday, reaching $8.00. 494,518 shares of the stock were exchanged, compared to its average volume of 1,914,571. Veradigm Inc. has a one year low of $5.01 and a one year high of $14.09. The stock's 50 day simple moving average is $8.04 and its 200-day simple moving average is $10.46.

Analyst Ratings Changes

A number of research firms have commented on MDRX. Barclays started coverage on Veradigm in a research note on Wednesday, January 3rd. They issued an "equal weight" rating and a $11.00 price objective on the stock. StockNews.com began coverage on Veradigm in a research note on Saturday, March 30th. They set a "hold" rating on the stock. Royal Bank of Canada lowered their price target on Veradigm from $22.00 to $11.00 and set an "outperform" rating for the company in a report on Friday, January 19th. Finally, Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a $10.00 price target (down from $15.00) on shares of Veradigm in a report on Tuesday, March 19th. Five analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $11.25.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.